Related references
Note: Only part of the references are listed.NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
HEPATOLOGY (2020)
The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing
Tianyu Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Circulating microbiota-derived metabolites: a liquid biopsy?
Gemma Aragones et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2020)
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases an therapy
John Y. L. Chiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota
Danfeng Chen et al.
CANCER LETTERS (2020)
Sodium acetate protects against nicotine-induced excess hepatic lipid in male rats by suppressing xanthine oxidase activity
E. O. Dangana et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies
Hamed Ebrahimzadeh Leylabadlo et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)
Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis
Cristy R. C. Verzijl et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice
Mingming Zhao et al.
GASTROENTEROLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3
Linqiang Ma et al.
HEPATOLOGY (2020)
Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
Haiming Hu et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
Mohammad Shadab Siddiqui et al.
JOURNAL OF HEPATOLOGY (2020)
Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?
Adryana Cordeiro et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2020)
Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD)
Clara Yieh Lin Chong et al.
NUTRIENTS (2020)
Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood
Xin Dai et al.
GUT MICROBES (2020)
Alteration of gut microbiota affects expression of adiponectin and resistin through modifying DNA methylation in high-fat diet-induced obese mice
Hongyang Yao et al.
GENES AND NUTRITION (2020)
Interleukin-22 protects intestinal stem cells against genotoxic stress
Konrad Gronke et al.
NATURE (2019)
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Serena Sanna et al.
NATURE GENETICS (2019)
Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases
Sabrina Campisano et al.
NUTRITION RESEARCH REVIEWS (2019)
Indole-3-Propionic Acid, a Tryptophan-Derived Bacterial Metabolite, Reduces Weight Gain in Rats
Piotr Konopelski et al.
NUTRIENTS (2019)
Leaky gut: mechanisms, measurement and clinical implications in humans
Michael Camilleri
GUT (2019)
Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease
Xuying Tan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats
Ze-Hua Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Judith Aron-Wisnewsky et al.
CURRENT DIABETES REPORTS (2019)
A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO)
Luigi Barrea et al.
NUTRIENTS (2019)
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
Ze-Hua Zhao et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages (vol 23, pg 1099, 2018)
Smitha Krishnan et al.
CELL REPORTS (2019)
Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases
Soraya Taleb
FRONTIERS IN IMMUNOLOGY (2019)
Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
Yun Ji et al.
NUTRIENTS (2019)
Acetate Affects the Process of Lipid Metabolism in Rabbit Liver, Skeletal Muscle and Adipose Tissue
Lei Liu et al.
ANIMALS (2019)
Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress
Shi Zilu et al.
AGING-US (2019)
The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk et al.
EMBO MOLECULAR MEDICINE (2019)
SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis
Mengting Chen et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
Gut microbial metabolites in obesity, NAFLD and T2DM
Emanuel E. Canfora et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Obeticholic acid: towards first approval for NASH
Mohammed Eslam et al.
LANCET (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Mining the microbiota for microbial and metabolite-based immunotherapies
Ashwin N. Skelly et al.
NATURE REVIEWS IMMUNOLOGY (2019)
An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity
Esther Nistal et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2019)
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Na Jiao et al.
GUT (2018)
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
Puneet Puri et al.
HEPATOLOGY (2018)
Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study
Jeremy F. L. Cobbold et al.
HEPATOLOGY RESEARCH (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Butyrate promotes visceral hypersensitivity in an IBS-like model via enteric glial cell-derived nerve growth factor
X. Long et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
The microbial metabolite indole-3-propionic acid improves glucose metabolism in rats, but does not affect behaviour
Anders Abildgaard et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2018)
The hepatic BMAL1/AKT/lipogenesis axis protects against alcoholic liver disease in mice via promoting PPAR pathway
Deqiang Zhang et al.
HEPATOLOGY (2018)
Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota
Carolina Serena et al.
ISME JOURNAL (2018)
A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial
Nazarii Kobyliak et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles et al.
NATURE MEDICINE (2018)
Translocation of a gut pathobiont drives autoimmunity in mice and humans
S. Manfredo Vieira et al.
SCIENCE (2018)
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Hannah E. Da Silva et al.
SCIENTIFIC REPORTS (2018)
Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
Loek P. Smits et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Short-Chain Fatty Acids Differentially Affect Intracellular Lipolysis in a Human White Adipocyte Model
Johan W. E. Jocken et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot
Ahmed Abdel-Razik et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target
Manuel H. Janeiro et al.
NUTRIENTS (2018)
Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Luigi Barrea et al.
NUTRIENTS (2018)
Acute oral sodium propionate supplementation raises resting energy expenditure and lipid oxidation in fasted humans
Edward S. Chambers et al.
DIABETES OBESITY & METABOLISM (2018)
Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives
Juan P. Arab et al.
HEPATOLOGY (2017)
Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals
Emanuel E. Canfora et al.
GASTROENTEROLOGY (2017)
Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
Oscar Chavez-Talavera et al.
GASTROENTEROLOGY (2017)
Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial
Elina Manzhalii et al.
JOURNAL OF DIGESTIVE DISEASES (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Amino acid profile and metabolic syndrome in a male Mediterranean population: A cross-sectional study
A. Ntzouvani et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)
Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Da Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue
Rebecca C. Schugar et al.
CELL REPORTS (2017)
Role of free fatty acids in endothelial dysfunction
Arijit Ghosh et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study
Cyriac Abby Philips et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Dysbiosis and the immune system
Maayan Levy et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
BMC MEDICINE (2017)
Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease
Anna Janina Engstler et al.
GUT (2016)
Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial
Abbaszadeh Sepideh et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2016)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu et al.
CELL (2016)
Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis
Filipe De Vadder et al.
CELL METABOLISM (2016)
FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues
Christian Schlein et al.
CELL METABOLISM (2016)
Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men
Christina M. van der Beek et al.
CLINICAL SCIENCE (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome (vol 45, pg 802, 2016)
Chuansheng Guo et al.
IMMUNITY (2016)
Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice
Anuradha Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Associations of gut-floradependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
Yu-ming Chen et al.
SCIENTIFIC REPORTS (2016)
Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
Baohong Wang et al.
SCIENTIFIC REPORTS (2016)
Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH)
Cheng Jun Jin et al.
BRITISH JOURNAL OF NUTRITION (2015)
The role of polydextrose in body weight control and glucose regulation
Emanuel E. Canfora et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2015)
Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
Venkatanarayana Gangarapu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Urinary 1H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment
A. Miccheli et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation
Hyo Kyun Chung et al.
LIVER INTERNATIONAL (2015)
Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome
Laurence Macia et al.
NATURE COMMUNICATIONS (2015)
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Edward S. Chambers et al.
GUT (2015)
The Gut Microbiota and Liver Disease
Cristina Llorente et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease
Sonia Michail et al.
FEMS MICROBIOLOGY ECOLOGY (2015)
Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis
A. Alisi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
Nagendra Singh et al.
IMMUNITY (2014)
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
Xiang Gao et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2014)
Obeticholic acid for the treatment of fatty liver disease—NASH no more?
Katrina Ray
Nature Reviews Gastroenterology & Hepatology (2014)
Identification of a Functional TPH1 Polymorphism Associated With Irritable Bowel Syndrome Bowel Habit Subtypes
Helmut Grasberger et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women
Evelyne M. Dewulf et al.
GUT (2013)
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Tiphaine Le Roy et al.
GUT (2013)
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
Lixin Zhu et al.
HEPATOLOGY (2013)
A Mixture of trans-Galactooligosaccharides Reduces Markers of Metabolic Syndrome and Modulates the Fecal Microbiota and Immune Function of Overweight Adults
Jelena Vulevic et al.
JOURNAL OF NUTRITION (2013)
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
G. M. Tannahill et al.
NATURE (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
Hitoshi Endo et al.
PLOS ONE (2013)
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
Vincent Wai-Sun Wong et al.
ANNALS OF HEPATOLOGY (2013)
Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance
Haihong Zong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2
Gwen Tolhurst et al.
DIABETES (2012)
Orphan Nuclear Receptor Small Heterodimer Partner Negatively Regulates Growth Hormone-mediated Induction of Hepatic Gluconeogenesis through Inhibition of Signal Transducer and Activator of Transcription 5 (STAT5) Transactivation
Yong Deuk Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans
Reiner Jumpertz et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
The G-Protein-Coupled Bile Acid Receptor, Gpbar1 (TGR5), Negatively Regulates Hepatic Inflammatory Response Through Antagonizing Nuclear Factor Kappa Light-Chain Enhancer of Activated B Cells (NF-κB) in Mice
Yan-Dong Wang et al.
HEPATOLOGY (2011)
Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease
Pietro Vajro et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Human nutrition, the gut microbiome and the immune system
Andrew L. Kau et al.
NATURE (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers
Luying Peng et al.
JOURNAL OF NUTRITION (2009)
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski et al.
NATURE (2009)
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice:: Role of endotoxin
Ina Bergheim et al.
JOURNAL OF HEPATOLOGY (2008)
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
Buck S. Samuel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats
Wan-Chun Wu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Kinetics and metabolism of Bifidobacterium adolescentis MB 239 growing on glucose, galactose, lactose, and galactooligosaccharides
Alberto Amaretti et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
T Claudel et al.
GASTROENTEROLOGY (2003)
Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans
D Letexier et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2003)
Bile acids induce the expression of the human peroxisome proliferator-activated receptor α gene via activation of the farnesoid X receptor
IP Torra et al.
MOLECULAR ENDOCRINOLOGY (2003)
Increased gastrointestinal ethanol production in obese mice: Implications for fatty liver disease pathogenesis
K Cope et al.
GASTROENTEROLOGY (2000)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Share Paper
